Global Bruton Tyrosine Kinase Btk Inhibitors Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 9.07 Billion |
 Market Size (Forecast Year) |
USD 16.79 Billion |
 CAGR |
% |
| Major Markets Players |
>全球布鲁顿酪氨酸激酶 (BTK) 抑制剂市场，按类型（第一代、第二代）、药物类型（Imbruvica、Calquence、Brukinsa）、应用（慢性淋巴细胞白血病 (CLL)、滤泡性淋巴瘤、套细胞淋巴瘤、边缘区淋巴瘤、小淋巴细胞淋巴瘤 (SLL)、华氏巨球蛋白血症、其他选择性 B 细胞恶性肿瘤、慢性移植物抗宿主病、其他）、最终用户（医院、专科诊所、家庭护理、其他）、分销渠道（医院药房、零售药房、网上药房、其他）划分 - 行业趋势和预测到 2029 年。
市场分析和规模
近年来，布鲁顿酪氨酸激酶 (BTK) 抑制剂市场预计在预测期内快速增长。B 细胞受体 (BCR) 信号通路包括布鲁顿酪氨酸激酶 (BTK)。在不同的 B 细胞淋巴瘤中，包括慢性淋巴细胞白血病 (CLL)，布鲁顿酪氨酸激酶是一种调节细胞增殖 (生长) 和细胞存活的必需蛋白质。因此，在癌症中使用 BTK 抑制剂的理由是阻止这种信号传导并导致癌细胞死亡。因此，癌症患病率的上升估计会增加医疗保健领域对布鲁顿酪氨酸激酶 (BTK) 抑制剂的需求。
Data Bridge Market Research 分析称，布鲁顿酪氨酸激酶 (BTK) 抑制剂市场在 2021 年的价值为 90.7 亿美元，预计到 2029 年将达到 167.9 亿美元，在 2022 年至 2029 年的预测期内复合年增长率为 8.00%。Data Bridge Market Research 团队策划的市场报告包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。
市场定义
非受体酪氨酸激酶抑制剂，如布鲁顿酪氨酸激酶 (BTK) 抑制剂，用于治疗 B 细胞疾病、白血病、淋巴瘤和其他癌症。靶向 B 细胞受体会影响 B 细胞信号传导、增殖和生长。布鲁顿酪氨酸激酶 (BTK) 抑制剂已被证明可有效治疗血液系统恶性肿瘤以及移植物抗宿主病 (GVDH)。这些抑制剂在髓系细胞的 BCR 信号传导和 FcR 信号传导中起关键作用。
报告范围和市场细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制至 2019 - 2014） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
Type (First Generation, Second Generation), Drug Type (Imbruvica, Calquence, Brukinsa), Application (Chronic Lymphocytic Leukemia (CLL), Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Small Lymphocytic Lymphoma (SLL), Waldenstrom Macroglobulinemia, Other Selective B Cell Malignancies, Chronic Graft-versus-host Disease, Other), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
AbbVie Inc. (US), AstraZeneca (UK), Johnson & Johnson Private Limited (US), Merck & Co., Inc. (US), Gilead Sciences, Inc. (US), Takeda Pharmaceutical Company Limited (Japan), Bristol-Myers Squibb Company (US), BeiGene (China), InnoCare (China), Sanofi (France), Novartis AG (Switzerland), Carna Biosciences, Inc. (Japan), Loxo Oncology (US), Aptose Biosciences Inc. (Canada), Biogen (US), Eli Lilly and Company (US), Agilent Technologies, Inc.(US), Eternity Bioscience Inc. (US) |
|
Market Opportunities |
|
Bruton Tyrosine Kinase (BTK) Inhibitors Market Dynamics
Drivers
- Increasing prevalence of chronic diseases
The rising prevalence of chronic diseases such as cancer, diabetes and others is anticipated to propel the Bruton tyrosine kinase (BTK) inhibitors? market's growth.
- Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of Bruton tyrosine kinase (BTK) inhibitors? market is the rising healthcare expenditure which helps in improving its infrastructure.
Furthermore, rising initiatives by public and private organizations to spread awareness will expand the Bruton tyrosine kinase (BTK) inhibitors? market. Additionally, high disposable income and changing lifestyle of people will result in the expansion of Bruton tyrosine kinase (BTK) inhibitors? market. Along with this, rising geriatric population and favourable reimbursement policies will enhance the market's growth rate.
Opportunities
- Increase in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the Bruton tyrosine kinase (BTK) inhibitors? market growth. Along with this, rising drug approvals and launches will further propel the 'market's growth rate.
Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the Bruton tyrosine kinase (BTK) inhibitors? market growth during the forecast period.
Restraints/Challenges
On the other hand, the drug approval hindrances and off targeting of first generation Bruton tyrosine kinase (BTK) inhibitors will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the Bruton tyrosine kinase (BTK) inhibitors? market. Additionally, side effects linked with Bruton tyrosine kinase (BTK) inhibitors and increasing prevalence of cardiovascular diseases will act as market restraints and further impede market growth rate during the forecast period of 2022-2029.
This Bruton tyrosine kinase (BTK) inhibitors? market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Bruton tyrosine kinase (BTK) inhibitors? market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
Bruton tyrosine kinase (BTK) inhibitors? market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
COVID-19 Impact on Bruton Tyrosine Kinase (BTK) Inhibitors Market
自 2019 年 12 月出现以来，COVID-19 病毒已传播到地球上几乎每个国家，促使世界卫生组织 (WHO) 宣布其为公共卫生紧急事件。这可以归因于其各自的制造和供应链运营严重中断，这是由于世界各国政府实施的多次预防性封锁和其他限制措施造成的。布鲁顿酪氨酸激酶 (BTK) 抑制剂市场也不例外。此外，由于大多数人的整体经济状况受到此次疫情的不利影响，消费者偏好有所下降，因为人们现在更加专注于从预算中消除非必要开支。在预测期内，上述因素可能会对布鲁顿酪氨酸激酶 (BTK) 抑制剂市场的收入轨迹产生负面影响。
全球布鲁顿酪氨酸激酶 (BTK) 抑制剂市场范围
布鲁顿酪氨酸激酶 (BTK) 抑制剂市场根据类型、药物类型、应用、最终用户和分销渠道进行细分。这些细分市场之间的增长将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
类型
- 第一代
- 第二代
根据类型，布鲁顿酪氨酸激酶 (BTK) 抑制剂市场分为第一代和第二代。
药物类型
- 依鲁替尼
- 钙化
- 布鲁金莎
根据药物类型，布鲁顿酪氨酸激酶 (BTK) 抑制剂市场分为 imbruvica、calquence 和 brukinsa。
应用
- 慢性淋巴细胞白血病 (CLL)
- 滤泡性淋巴瘤
- 套细胞淋巴瘤
- 边缘区淋巴瘤
- 小淋巴细胞淋巴瘤 (SLL)
- 瓦尔登斯特伦巨球蛋白血症
- 其他选择性 B 细胞恶性肿瘤
- 慢性移植物抗宿主病
- 其他的
根据应用，布鲁顿酪氨酸激酶 (BTK) 抑制剂市场细分为慢性淋巴细胞白血病 (CLL)、滤泡性淋巴瘤、套细胞淋巴瘤、边缘区淋巴瘤、小淋巴细胞淋巴瘤 (SLL)、华氏巨球蛋白血症、其他选择性 B 细胞恶性肿瘤、慢性移植物抗宿主病等。
最终用户
- 医院
- 专科诊所
- 家庭护理
- 其他的
根据最终用户，布鲁顿酪氨酸激酶 (BTK) 抑制剂市场分为医院、专科诊所、家庭护理和其他。
分销渠道
- 医院药房
- 零售药店
- 网上药店
- 其他的
根据分销渠道，布鲁顿酪氨酸激酶 (BTK) 抑制剂市场也细分为医院药房、零售药房、网上药房和其他。
布鲁顿酪氨酸激酶 (BTK) 抑制剂市场区域分析/见解
对布鲁顿酪氨酸激酶 (BTK) 抑制剂市场进行了分析，并按上述国家、类型、药物类型、应用、最终用户和分销渠道提供了市场规模见解和趋势。
布鲁顿酪氨酸激酶 (BTK) 抑制剂市场报告涵盖的国家包括北美的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区（中东和非洲的一部分）、巴西、阿根廷和南美洲的其他地区（南美洲的一部分）
由于北美地区研发活动不断增加，北美在布鲁顿酪氨酸激酶 (BTK) 抑制剂市场占据主导地位。此外，慢性病患病率的上升和主要关键参与者的不断增加将进一步推动该地区市场的增长速度。
由于医疗保健支出的增加和医疗保健基础设施的改善，预计亚太地区在预测期内将实现增长。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和布鲁顿酪氨酸激酶 (BTK) 抑制剂市场份额分析
布鲁顿酪氨酸激酶 (BTK) 抑制剂市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对布鲁顿酪氨酸激酶 (BTK) 抑制剂市场的关注有关。
布鲁顿酪氨酸激酶 (BTK) 抑制剂市场的一些主要参与者包括：
- AbbVie Inc.（美国）
- 阿斯利康（英国）
- 强生私人有限公司（美国）
- 默克公司（美国）
- 吉利德科学公司（美国）
- 武田药品工业株式会社 (日本)
- 百时美施贵宝公司 (美国)
- 百济神州 (中国)
- 诺诚健华 (中国)
- 赛诺菲（法国）
- 诺华公司（瑞士）
- Carna Biosciences, Inc.（日本）
- Loxo Oncology（美国）
- Aptose Biosciences Inc.（加拿大）
- Biogen（美国）
- 礼来公司 (美国)
- 安捷伦科技公司（美国）
- Eternity Bioscience Inc.（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
